Sonic Healthcare Ltd
SHL
Company Profile
Business description
Sonic Healthcare is a global pathology provider. It is the largest private operator in Australia, Germany, Switzerland and the UK, the second-largest in Belgium and New Zealand, and the third largest in the US. In addition to pathology, which contributes roughly 85% of group revenue, Sonic is the second-largest player in diagnostic imaging in Australia and the largest operator of medical centers in Australia. The company typically earns about 40% of group revenue in Australia and New Zealand, 25% in the US, and 35% in Europe.
Contact
225 George Street
Level 22, Grosvenor Place
SydneyNSW2000
AUST: +61 298555444
Sector
Healthcare
Stock type
Defensive
Industry
Diagnostics & Research
Fiscal Year End
30 June 2026
Employees
41,000
Stocks News & Analysis
stocks
What we think of the 3 big winners of the ASX 100
Exploring the ASX companies who dominated the market this year
stocks
Ask the analyst: Why have Healius shares struggled so much?
Shares in Australia's second biggest pathology operator have floundered in recent years. Shane Ponraj thinks better days could be ahead.
personal-finance
Top 8 ASX dividend shares
These undervalued shares with moats have attractive and potentially growing dividends.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,777.80 | 50.90 | -0.58% |
CAC 40 | 7,766.71 | 43.24 | 0.56% |
DAX 40 | 24,206.91 | 133.24 | 0.55% |
Dow JONES (US) | 44,240.76 | 165.60 | -0.37% |
FTSE 100 | 8,854.18 | 47.65 | 0.54% |
HKSE | 23,894.80 | 253.27 | -1.05% |
NASDAQ | 20,418.46 | 5.95 | 0.03% |
Nikkei 225 | 39,762.84 | 74.03 | 0.19% |
NZX 50 Index | 12,768.61 | 90.41 | -0.70% |
S&P 500 | 6,225.52 | 4.46 | -0.07% |
S&P/ASX 200 | 8,538.60 | 52.10 | -0.61% |
SSE Composite Index | 3,503.83 | 6.36 | 0.18% |